Where does invoX Pharma Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), invoX Pharma Limited ranks #26,595 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does invoX Pharma Limited hold?

invoX Pharma Limited holds 10 US utility patents granted between 2024 and 2025, spanning 6 technology areas.

What is invoX Pharma Limited's Innovation Score?

invoX Pharma Limited has an Innovation Score of 37.2 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does invoX Pharma Limited focus on?

invoX Pharma Limited's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 10 patents, ranking #2,196 of 7,163 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is invoX Pharma Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for invoX Pharma Limited.

What does claim depth mean for invoX Pharma Limited's patents?

invoX Pharma Limited's patents average 22.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the invoX Pharma Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

invoX Pharma Limited

USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, invox ranks #26,595 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.

#26,595
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.2/100): 22.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R26595 · Foreign Corporation #26,595 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 10 grants
MID-PACK #26,595/49,997
PHOTO-FINISH eBay Korea
CPC-NARROW A61K · 6 areas
INNOV-THIN 37.2/100
CLAIMS-DENSE 22.7 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2024–2025 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: eBay Korea Co. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How invox’s 37.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (22%) Velocity 6.7 pts (18%) Breadth 8.7 pts (23%) Claim depth 13.6 pts (36%)

Qualcomm Incorporated · highest

85
Easton Diamond Sports · near

37
Intelligent Medical… · near

37
invoX Pharma · this assignee

37
NETZCH-Feinmahltechnik · near

37
Think Green · near

37
3D Lighting… · lowest

7

What this shows invox's Innovation Score is 37.2/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for invox?

Each dot is one of invox’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). invox’s own 22.7 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

invox vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where invox's grants concentrate

invoX Pharma Limited is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). By volume, invox sits between e.l.f. Cosmetics, Inc. and pewag austria GmbH.

invox's three-year grant acceleration

invoX Pharma Limited shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

e l f Cosmetics

10
ebay Korea

10
ezono

10
iomniscient Pty

10
jsonar

10
ncino

10
ndd Medizintechnik

10
pewag austria

10
invox Pharma ◀

10

What this shows invoX holds 10 patents at rank #27,920, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near invoX

By rank, the assignees closest to #27,920 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in invoX's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for invoX, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), invoX ranks #2,196 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Intelligent Medical Objects, Inc. 37 NETZCH-Feinmahltechnik GmbH 37 Think Green Limited 37 Easton Diamond Sports, LLC 37

invox's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

invoX Pharma Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	1	10.0%
2025partial year	9	90.0%

Which technologies does invoX Pharma Limited patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

C07K - Peptides 9

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

invoX Pharma Limited's patent record in context - here's where to go next.

invoX Pharma Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #26,595 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare invoX Pharma Limited against e.l.f. Cosmetics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.